Pseudoephedrine Hydrochloride, a small molecule drug, acts as an α-adrenergic receptor agonist, exerting its effects through the stimulation of α-adrenergic receptors. The drug, first approved in August 1975, is primarily utilized as a decongestant to alleviate nasal congestion caused by a variety of factors, such as the common cold, allergies, or sinusitis. Pseudoephedrine Hydrochloride operates by eliciting a response from the α-adrenergic receptors present in the smooth muscle of the blood vessels located in the nasal passages, inducing constriction and mitigating the swelling of the nasal mucosa. This process culminates in an augmented airflow through the nasal passages, relieving congestion. However, owing to its potential for abuse and the production of illegal drugs, pseudoephedrine-containing medications are currently subject to strict regulation and require a prescription in numerous countries to prevent their misuse. Click on the image below to begin the exploration journey of Pseudoephedrine through the Synapse database!
You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!